BRCA1 and BRCA2 Gene Mutations: What They Mean for Your Risk

When people are made aware of BRCA1 and BRCA2 gene mutations, they often view them as unusual and associated with a cancer diagnosis. However, in reality, everyone has BRCA genes. They are a vital component that helps protect your DNA. A mutation is not a new gene; rather, it is a weakening of a gene that is already present in your system.

The frequency of these gene mutations is higher than one might think. In fact, 1 in 400 people are at a higher risk of having a BRCA mutation. However, this figure is higher for those who are of Ashkenazi Jewish descent; their figure is 1 in 40. Knowing your BRCA mutation is one of the most empowering pieces of information that can be made available to a person.

In this article, we will discuss what the BRCA1 and BRCA2 genes actually do, the differences between both, BRCA mutations and associated cancers, and what you can do if the test is positive.

Read More: No More Needles: How Liquid Biopsies Are Transforming Advanced Cancer Monitoring

What Do BRCA1 and BRCA2 Genes Actually Do?

To understand what the BRCA genes actually do, think of the BRCA1 and BRCA2 genes like the quality control managers in your cells. They help in repairing damage to the DNA. This is the worst kind of damage that can occur in the DNA of a cell. It is referred to as a “double-strand” break in the DNA.

The two genes are tumor suppressors. They don’t stop cancer in any way. They simply stop the conditions that allow cancer to develop. Everyone has two copies of each of the two genes. If the genes in one of the pairs are damaged in some way, the other gene in the pair can often compensate for the damage, at least until later in life.

The risk of cancer occurs when the other gene in the pair is damaged as well. This is the reason that cancers associated with the BRCA genes tend to occur earlier in life than other cancers that are not inherited. It is also important to note that while the risk of having the genes is significant, 90-95% of cancers are not inherited.

BRCA1 vs BRCA2: The Differences That Matter for Your Risk and Treatment

The difference between BRCA1 and BRCA2 is not merely semantic; it has real implications for cancer behavior, prevention, and treatment. Carriers of BRCA1 have a 55-72% chance of breast cancer risk over their lifetime.

These breast cancer risks are also more likely to be triple-negative, meaning they do not have estrogen, progesterone, or HER2 receptors. This means that hormone therapy such as tamoxifen is not typically effective. Chemotherapy is more frequently used.

Carriers of BRCA2 have a slightly smaller risk of breast cancer, ranging from 45% to 69%. These breast cancer risks are more likely to have hormone receptors. This means that targeted therapy, such as tamoxifen, can significantly reduce the risk of recurrence.

Ovarian cancer is also more common among women with BRCA1. These women have a 39–58% risk of ovarian cancer over their lifetime. Women with BRCA2 have a 13–29% risk. In addition, ovarian cancer associated with BRCA1 mutations tends to occur at a younger age. Women with BRCA mutations also face a higher risk of developing a second (contralateral) breast cancer.

Read More: What Early Onset Breast Cancer Feels Like — Signs You Shouldn’t Ignore

Other Cancers Associated with BRCA Mutations

While breast and ovarian cancer are always discussed, a few other variants are little known.

The risk of pancreatic cancer is slightly but significantly elevated, especially for BRCA2, where it can be as high as 10%. This has sparked considerable research into pancreatic cancer screening for those at high risk.

Prostate cancer is one of the biggest concerns for men who carry a BRCA mutation, especially BRCA2. Here, it is possible for it to be as high as 61%. These are more aggressive forms of cancer that occur at a younger age.

Male breast cancer, although a rare cancer, is more relevant when discussing BRCA2. Here, it is possible for it to be as high as 7.1%, which is dozens of times higher than in the general population. There is emerging evidence that melanoma may be linked to BRCA2, so this may be worth considering, too.

BRCA Mutations in Men: What You Need to Know

One area where there is a big gap in understanding is how the BRCA mutations affect men. Men receive BRCA mutations just as frequently as women. However, they are much less likely to be tested for and receive BRCA genetic counseling.

For BRCA2 mutation carriers, prostate cancer is a major concern. The recommendations for prostate cancer screening for BRCA2 mutation carriers include starting annual testing at age 40, much younger than for the general public.

Risk for breast cancer in men is also an issue. Though it is still relatively rare, it is high enough to warrant regular breast exams and an awareness of symptoms such as lumps and changes in the nipple area.

Men also have an important role in transmitting BRCA mutations. If a woman is identified as having a BRCA mutation, she likely inherited it from her father. Her brothers and sons each have a 50% chance of being carriers.

Who Should Get BRCA Testing? Updated 2024 Criteria

The question of who should undergo BRCA testing has become clearer with the updated recommendations. As of 2024, all individuals diagnosed with breast cancer at the age of 65 years or younger should undergo BRCA gene testing, even if they don’t have a family history.

If someone doesn’t have breast cancer, the recommendations for BRCA testing are based on risk factors. They include a person’s history of breast cancer diagnosed before the age of 50, ovarian cancer diagnosed at any age, male breast cancer, pancreatic cancer, or aggressive prostate cancer.

Ashkenazi Jewish descent is another significant risk factor because this ethnic group has a higher incidence of founder mutations. However, it is not recommended to undergo BRCA testing if one is younger than 18 years old because it will not affect the management plan during this period and could lead to unnecessary anxiety.

How BRCA Testing Works — and What Your Results Actually Mean

How the Test is Done

The BRCA gene test is easy and available. It only requires a blood test, saliva test, or cheek test. Clinical BRCA testing, which is ordered through a healthcare provider, tests the entire sequence of the gene. This type of testing is the most accurate.

Direct-to-consumer BRCA testing only tests for a few known mutations in the gene. This type of testing may not detect the vast majority of BRCA mutations in individuals without certain ancestral backgrounds. The results of a negative test should not be taken as conclusive.

Understanding Results: Positive, Negative, and VUS

If the result is positive, it confirms the presence of the cancer-causing mutation. It does not mean that you have cancer, but it does significantly increase your lifetime risk and makes you eligible for more intense cancer screening and prevention.

What a BRCA-negative result means:

• If a known family mutation exists, a negative result means that the risk of having cancer is at the population level.
• If no known family mutation exists, a negative result has limited information.

What does a variant of uncertain significance (VUS) result mean:

VUS accounts for 5% of the results obtained so far. This is one of the most commonly misunderstood results. VUS does not mean that the risk of cancer has increased. VUS mutations are usually reclassified as benign in the future, so no medical decisions should be made based on a VUS result.

Why Genetic Counseling Matters

BRCA genetic counseling is essential before and after testing. Before testing, it ensures you understand the implications and limitations. After testing, it helps translate results into a clear action plan. Counselors also guide conversations with family members and help coordinate BRCA cascade testing family strategies, which can identify at-risk relatives early.

Read More: Genetic Testing for Hypertrophic Cardiomyopathy: Should Your Family Get Screened?

If You Test Positive: Your Risk-Reduction Options

If you are BRCA positive, knowing what to do next is critical. While there is no single solution that fits all, there are several proven BRCA risk reduction strategies. First, there is enhanced surveillance. Women can begin annual MRI scans at age 25 and mammograms at age 30. Males with BRCA2 can begin a PSA at age 40. Medication is also a viable option.

Tamoxifen is used for hormone receptor-positive breast cancer. This makes it more appropriate for BRCA2 than BRCA1. Preventive surgery is also an option that offers the greatest risk reduction. A prophylactic mastectomy can reduce breast cancer risk by as much as 95 percent.

A risk-reducing salpingo-oophorectomy can reduce ovarian cancer risk by 80 percent. This also reduces breast cancer risk if done before menopause. In the unfortunate event that cancer does occur, BRCA treatments have changed the course of cancer. Specifically, targeted therapies such as PARP inhibitor drugs like olaparib and talazoparib work. These drugs target the DNA repair defect caused by BRCA mutations.

Telling Your Family — and Why Cascade Testing Could Save Their Lives

One of the most important steps after a positive result is informing your family. Through BRCA cascade testing of family members, first-degree relatives, including parents, siblings, and children, can be tested for the same mutation.

Each relative has a 50% chance of carrying it. Those who test positive can take preventive action early, while those who test negative can avoid unnecessary anxiety and screening. Healthcare providers often supply structured family letters to make these conversations clearer and more accurate.

Cascade testing is considered one of the most cost-effective cancer prevention strategies available.

What BRCA Testing Means for Insurance — and Your Emotional Health

Genetic testing has its own “real world” issues, too. GINA, in the U.S., protects against discrimination in health insurance and employment. However, it does not protect against discrimination in life, disability, or long-term care insurance.

Some people may wish to obtain these insurance policies before undergoing a test. While most people do not experience problems, a small percentage of people do. Emotionally, learning about one’s BRCA status is a complex issue. Some people find it liberating, while others find it worrying or uncertain.

Support groups, including “previvor” groups, can help reduce concerns. Mental health support is a necessity, not a luxury, in dealing with hereditary breast and ovarian cancer.

Read More: How AI Is Used to Predict Health Risks and Prevent Disease

Conclusion

Having BRCA1 and BRCA2 gene mutations is not a diagnosis; it’s a powerful piece of information. It allows you to take control through earlier screening, informed prevention, and access to targeted treatments.

If you’ve ever wondered about what BRCA gene testing is or whether your family history puts you at risk, now is the time to act. A conversation with a healthcare provider or genetic counselor can clarify your next steps and potentially change the course of your health.

FAQs

Q. What is the BRCA gene, and how does it increase cancer risk?

A. The BRCA gene helps repair DNA damage. When mutated, this repair process fails, increasing the likelihood of breast, ovarian, and other cancers.

Q. What is the BRCA mutation breast cancer risk for women?

A. BRCA1 carriers have a 60–72% lifetime risk, while BRCA2 carriers have a 45–69% risk, significantly higher than average.

Q. Who should get BRCA testing according to current guidelines?

A. Anyone with a strong family history of related cancers, Ashkenazi Jewish ancestry, or a breast cancer diagnosis at age 65 or younger should consider testing.

Q. What does a BRCA-negative result mean?

A. It depends on whether a known family mutation exists. Without that, a negative result does not completely rule out inherited risk.

Q. What are PARP inhibitors and BRCA treatments used for?

A. They are targeted therapies, including olaparib and talazoparib, used to treat BRCA-related cancers by exploiting DNA repair defects.

Q. If I am BRCA positive, what do I do next?

A. Start with genetic counseling, then explore screening, medications, and preventive surgeries based on your personal risk and goals.